Selected research
Industry Growth & Trends
Global Anti-Smoking Products Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Anti-Smoking Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Anti-Smoking Products market include Takeda pharmaceutical, Novartis International, Pfizer, GSK, VMR products, VaporCorp, Revolymer plc, NJOY and McNeil AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Anti-Smoking Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Anti-Smoking Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Smoking Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Smoking Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Anti-Smoking Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Anti-Smoking Products Market by Company
Takeda pharmaceutical
Novartis International
Pfizer
GSK
VMR products
VaporCorp
Revolymer plc
NJOY
McNeil AB
Lorillard
Imperial Tobacco
Elder Pharma
Cipla
Anti-Smoking Products Segment by Type
Drug therapy
Nicotine Replacement Therapy
E-cigarettes
Anti-Smoking Products Segment by Application
Smokers aged 65 years or older
Smokers aged 45–64
Smokers aged 25–44
Smokers aged 18–24
Anti-Smoking Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Smoking Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Smoking Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Smoking Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Anti-Smoking Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drug therapy
- Nicotine Replacement Therapy
- E-cigarettes
Applications
- Smokers aged 65 years or older
- Smokers aged 45–64
- Smokers aged 25–44
- Smokers aged 18–24
Companies covered
- Takeda pharmaceutical
- Novartis International
- Pfizer
- GSK
- VMR products
- VaporCorp
- Revolymer plc
- NJOY
- McNeil AB
- Lorillard
- Imperial Tobacco
- Elder Pharma
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Anti-Smoking Products Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Anti-Smoking Products Market Size by Region (2021-2032)
- 1.4.1 Global Anti-Smoking Products Market Size by Region (2021-2026)
- 1.4.2 Global Anti-Smoking Products Market Size by Region (2027-2032)
- 1.5 Key Regions Anti-Smoking Products Market Size (2021-2032)
- 1.5.1 North America Anti-Smoking Products Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Anti-Smoking Products Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Anti-Smoking Products Market Size Growth Rate (2021-2032)
- 1.5.4 South America Anti-Smoking Products Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Anti-Smoking Products Market Size Growth Rate (2021-2032)
2 Anti-Smoking Products Market by Type
- 2.1 Type Introduction
- 2.1.1 Drug therapy
- 2.1.2 Nicotine Replacement Therapy
- 2.1.3 E-cigarettes
- 2.2 Global Anti-Smoking Products Market Size by Type
- 2.2.1 Global Anti-Smoking Products Market Size Overview by Type (2021-2032)
- 2.2.2 Global Anti-Smoking Products Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Anti-Smoking Products Market Size Forecasted by Type (2027-2032)
- 2.3 Global Anti-Smoking Products Market Size by Regions
- 2.3.1 North America Anti-Smoking Products Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Anti-Smoking Products Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Anti-Smoking Products Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Anti-Smoking Products Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Anti-Smoking Products Market Size Breakdown by Type (2021-2026)
3 Anti-Smoking Products Market by Application
- 3.1 Type Introduction
- 3.1.1 Smokers aged 65 years or older
- 3.1.2 Smokers aged 45–64
- 3.1.3 Smokers aged 25–44
- 3.1.4 Smokers aged 18–24
- 3.2 Global Anti-Smoking Products Market Size by Application
- 3.2.1 Global Anti-Smoking Products Market Size Overview by Application (2021-2032)
- 3.2.2 Global Anti-Smoking Products Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Anti-Smoking Products Market Size Forecasted by Application (2027-2032)
- 3.3 Global Anti-Smoking Products Market Size by Regions
- 3.3.1 North America Anti-Smoking Products Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Anti-Smoking Products Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Anti-Smoking Products Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Anti-Smoking Products Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Anti-Smoking Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Anti-Smoking Products Industry Trends
- 4.2 Anti-Smoking Products Industry Drivers
- 4.3 Anti-Smoking Products Industry Opportunities and Challenges
- 4.4 Anti-Smoking Products Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Anti-Smoking Products Revenue (2021-2026)
- 5.2 Global Anti-Smoking Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Anti-Smoking Products Key Company Headquarters & Area Served
- 5.4 Global Anti-Smoking Products Company, Product Type & Application
- 5.5 Global Anti-Smoking Products Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Anti-Smoking Products Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Anti-Smoking Products Players Market Share by Revenue in 2025
- 5.6.3 2025 Anti-Smoking Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Takeda pharmaceutical
- 6.1.1 Takeda pharmaceutical Company Information
- 6.1.2 Takeda pharmaceutical Business Overview
- 6.1.3 Takeda pharmaceutical Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Takeda pharmaceutical Anti-Smoking Products Product Portfolio
- 6.1.5 Takeda pharmaceutical Recent Developments
- 6.2 Novartis International
- 6.2.1 Novartis International Company Information
- 6.2.2 Novartis International Business Overview
- 6.2.3 Novartis International Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Novartis International Anti-Smoking Products Product Portfolio
- 6.2.5 Novartis International Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Pfizer Anti-Smoking Products Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 GSK
- 6.4.1 GSK Company Information
- 6.4.2 GSK Business Overview
- 6.4.3 GSK Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 GSK Anti-Smoking Products Product Portfolio
- 6.4.5 GSK Recent Developments
- 6.5 VMR products
- 6.5.1 VMR products Company Information
- 6.5.2 VMR products Business Overview
- 6.5.3 VMR products Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 VMR products Anti-Smoking Products Product Portfolio
- 6.5.5 VMR products Recent Developments
- 6.6 VaporCorp
- 6.6.1 VaporCorp Company Information
- 6.6.2 VaporCorp Business Overview
- 6.6.3 VaporCorp Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 VaporCorp Anti-Smoking Products Product Portfolio
- 6.6.5 VaporCorp Recent Developments
- 6.7 Revolymer plc
- 6.7.1 Revolymer plc Company Information
- 6.7.2 Revolymer plc Business Overview
- 6.7.3 Revolymer plc Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Revolymer plc Anti-Smoking Products Product Portfolio
- 6.7.5 Revolymer plc Recent Developments
- 6.8 NJOY
- 6.8.1 NJOY Company Information
- 6.8.2 NJOY Business Overview
- 6.8.3 NJOY Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 NJOY Anti-Smoking Products Product Portfolio
- 6.8.5 NJOY Recent Developments
- 6.9 McNeil AB
- 6.9.1 McNeil AB Company Information
- 6.9.2 McNeil AB Business Overview
- 6.9.3 McNeil AB Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 McNeil AB Anti-Smoking Products Product Portfolio
- 6.9.5 McNeil AB Recent Developments
- 6.10 Lorillard
- 6.10.1 Lorillard Company Information
- 6.10.2 Lorillard Business Overview
- 6.10.3 Lorillard Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Lorillard Anti-Smoking Products Product Portfolio
- 6.10.5 Lorillard Recent Developments
- 6.11 Imperial Tobacco
- 6.11.1 Imperial Tobacco Company Information
- 6.11.2 Imperial Tobacco Business Overview
- 6.11.3 Imperial Tobacco Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Imperial Tobacco Anti-Smoking Products Product Portfolio
- 6.11.5 Imperial Tobacco Recent Developments
- 6.12 Elder Pharma
- 6.12.1 Elder Pharma Company Information
- 6.12.2 Elder Pharma Business Overview
- 6.12.3 Elder Pharma Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Elder Pharma Anti-Smoking Products Product Portfolio
- 6.12.5 Elder Pharma Recent Developments
- 6.13 Cipla
- 6.13.1 Cipla Company Information
- 6.13.2 Cipla Business Overview
- 6.13.3 Cipla Anti-Smoking Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cipla Anti-Smoking Products Product Portfolio
- 6.13.5 Cipla Recent Developments
7 North America
- 7.1 North America Anti-Smoking Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Anti-Smoking Products Market Size by Country (2021-2026)
- 7.3 North America Anti-Smoking Products Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Anti-Smoking Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Anti-Smoking Products Market Size by Country (2021-2026)
- 8.3 Europe Anti-Smoking Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-Smoking Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Anti-Smoking Products Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Anti-Smoking Products Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Anti-Smoking Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Anti-Smoking Products Market Size by Country (2021-2026)
- 10.3 South America Anti-Smoking Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-Smoking Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Anti-Smoking Products Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Anti-Smoking Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst